A phase 1b/2 study of the BRAF inhibitor encorafenib plus...

  • Main
  • 2020 / 07
  • A phase 1b/2 study of the BRAF inhibitor encorafenib plus...

A phase 1b/2 study of the BRAF inhibitor encorafenib plus the MEK inhibitor binimetinib in patients with BRAF V600E/K-mutant solid tumors

Sullivan, Ryan J., Weber, Jeffrey S., Patel, Sapna P., Dummer, Reinhard, Carlino, Matteo S., Tan, Daniel Shao-Weng, Lebbe, Celeste, Siena, Salvatore, Élez, Elena, Wollenberg, Lance, Pickard, Michael,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-3550
Date:
July, 2020
File:
PDF, 457 KB
2020
Conversion to is in progress
Conversion to is failed